Contact

Via our
email form

or call on
020 7486 5566 (9am to 5pm)

07735 000 903 (out of hours)

Published Abstracts (Journals)

  1. Nargund VH, Parapia L, Flannigan GM, Stewart PAh, Crawford SM. Effect of commonly used
    intravesical drugs on the EGFR expression of established TCC cell lines. Journal of Oncology 1994;5:
    6

  2. Nargund VH, Yoshida K, Smith JC, Fellows GJ, Cranston DW, Tarin D. Telomerase activity in
    transitional cell carcinoma; its implications for non-invasive detection of bladder cancer. British
    Journal of Urology 1996; 77(Suppl): 10-11

  3. Nargund VH, Noble JG, Cranston D, Fellows GJ. P148: Haematuria: A long-term problem after
    prostatectomy. British Journal of Urology 1998; 81(4) (suppl): 50

  4. Fenely MR, Jan  H, Granowska M, Mather SJ, Ellison D, Oliver RTD, Badenoch DF, Chinegwundoh
    FC, Nargund VH, Paris AMI, Britton KE. P93: Prostate cancer imaging with Indium-111 labelled
    monoclonal antibody to prostate membrane specific antigen (PMSA). British Journal of Urology
    1998; 81: 30

  5. Nargund VH, Oliver RTD, Baithun S, Ong J, Sohaib A, Reznek R, Badenoch DF, Paris AMI. P23:
    Chemotherapy ±Partial orchidectomy for testis conservation in patients with germ cell cancer (GCC).
    British Journal of Urology 1998; 81(4): 4

  6. Otite U, Dacie J, Chan L, Mahesh Kumar, Nargund VH. Percutaneous antegrade stenting is still an
    effective treatment for malignant ureteric strictures. European Urology 2000; 37; 66

  7. Otite U, Nambirajan T, Chan L, Webb JA, Hendry WF, Nargund VH. Testicular microlithiasis: A
    benign condition with a malignant association or simply a premalignant condition? Journal of
    Urology 2000;163 (Suppl) ; 315

  8. Kumar M, Martin J, Nargund VH, Burney D. Expression of TGF receptors type1 and type 2 in
    superficial TCC bladder. British Journal of Cancer 2000; 83

  9. Kumar M, Martin J, Nargund VH, Burney D. Cyclooxygenase2 expression in superficial TCC of
    bladder. British Journal of Cancer 2000; 83

  10. Kumar M, Martin J, Otite U, Gordon S, Nargund V, Burney D. Role of Cyclooxygenase 2 in
    superficial TCC bladder. European Urology 2001; 39: 116

  11. Britton KE, Gordon SJ, Canizales A, Otite U, Mather SJ, Ellison D, Elnaas S, Jan H, Bander NH,
    Nargund VH. Prostate cancer imaging with 99Tcm-J591 monoclonal antibody against prostate specific
    membrane antigen. Nuclear Medicine Communications 2001; 22: 454

  12. Lucas M, Stephenson T and Nargund VH. Tamsulosin in the management of patients in acute
    urinary retention due to BPH. European Journal of Urology 2002; 1:106

  13. Gordon S, Otite U, Stewart E and Nargund V. Evaluation of 5% lignocaine ointment on patient
    tolerance to TRUS- prostatic biopsy. European Journal of Urology 2002; 1: 118

  14. Nargund VH, Lucas M, Stephenson T. Tamsulosin effectively reduces the need for
    recatheterisation in elderly male patients with a subsequent episode of acute urinary retention due
    to benign prostatic hyperplasia. British Journal of Urology International 2002;90(2):76-77

  15. Lucas M, Stephenson T, Nargund V. Tamsulosin reduces the need for recatheterisation in elderly
    male patients with a subsequent episode of acute urinary retention due to benign prostatic
    hyperplasia. Journal of Urology 2002; 167: 1047

  16. Otite U, Iles R, Jacoby E, Baithun S, Chinegwundoh F, Nargund V. Evaluation of serum and urinary
    human chorionic gonadotrophin beta and beta core fragment detected by immunoassay in the
    clinical management of prostate cancer. BJU International 2002; 90: 245

  17. Enver MK, Otite U, Iles R, Chinegwundoh FI, Persad R, Nargund VH. Elevated serum levels of the
    aminoterminal propeptide of type I procollagen (P1NP) are associated with a poor prognosis in
    metastatic prostate cancer. Prostate Cancer and Prosattic diseases 2003: 6: 90-1

  18. Bhardwa J, Maheshkumar P, Berney D, Martin JE, Nargund VH. Gene expression profiling of
    superficial bladder cancer using DNA chip technology. British Journal of Urology International 2003;
    92: 831

  19. Bharadwa J, Oliver RTD, Nargund VH, Berney D. Reduction in testicular germ cell cancer size with
    increasing awareness. British Journal of Cancer 2003; 88: S64

  20. Bharadwa J, Kumar M, Berney D, Martin J, Nargund VH. Genetic profiling of superficial bladder
    cancer. British Journal of Cancer 2003; 88: S50

  21. Bhardwa J, Sangtani BK and Nargund VH. A single centre audit of bladder cancer. British Journal
    of Cancer 2003; 88:  S72

  22. Gordon S J, Campbell S, Bhardwa J, Nargund V H. Testicular arterial blood flow in normal and
    azoospermic men. British Journal of Urology International 2003; 91(2): 87

  23. Carroll M J, El-Megadmi H, Elnaas S, Chilab S, Nargund V, Britton KE (P18). Prostate cancer:
    combined Prostascint SPET/CT/blood pool imaging. Nuclear Medicine Communications 2003;24:
    473

  24. Otite U, Iles R, Jacoby E, Baithun S, Chinegwundoh F and Nargund VH. Evaluation of serum and
    urinary human chorionic gonadotrophin beta and beta core fragment detected by immunoassay in
    the clinical management of prostate cancer. British Journal of Urology International 2002; 90: 245

  25. Gordon S J, Campbell SC, Nargund VH. Testicular arterial blood flow as a marker of
    spermatogenesis. Journal of Urology 2004; 171 (4); 413

  26. Nargund VH, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M,  Britton K. Imaging
    with radiolabelled monoclonal antibody specific for extracellar domain of prostate specific
    membrane antigen (PSMA) in staging prostate carcinoma for patients undergoing radical
    prostatectomy.  Journal of Urology 2004; 171(4): 518 (No.1963)

  27. Bhardwa J, M,Berney D, Baithun S, Nargund V H, Oliver R T D. Reduction in the size of testicular
    germ cell tumours 1960-2003. British Journal of Urology (Suppl 4) 2004; 93:19

  28. Kumar P, Bhardwa J, Kapoor S, Nargund V H. Treatment of anastomotic strictures following
    radical prostatectomy: An alternative approach using balloon dilatation. British Journal of Urology
    International 2004; 94 (Suppl 2): 210

  29. Kumar P, Nargund V H. Samual Pepys: A patient. British Journal of Urology International 2004; 94
    (Suppl  2) : 301 (UP-19.06)

  30. Brennen N, Ghani K, Nargund V H. Changes: A survey of BAUS members on modernising Urology.
    British Journal of Urology International 2006; 97 (Suppl 3): 2 (015)

  31. Kumar P, Baithun S I, Oliver RTD, Nargund V. Angiogenesis and Lymphangiogenesis in testicular
    germ cell tumours (TGCT). British Journal of Urology International 2006; 97 (Suppl 3): 13 (053)

  32. Bose PS, Kumar P, Nargund V, Pati J. Non-attendance in outpatients: causes and remedies.
    British Journal of Urology International 2006; 97 (Suppl 3): 69 (P065)